Femtrace
Generic name: Estradiol Oral
Drug class:
Estrogens
Usage of Femtrace
Femtrace is a form of estrogen, a female sex hormone produced by the ovaries. Estrogen is necessary for many processes in the body.
Femtrace is used to treat symptoms of menopause such as hot flashes, and vaginal dryness, burning, and irritation. Other uses include prevention of osteoporosis in postmenopausal women, and replacement of estrogen in women with ovarian failure or other conditions that cause a lack of natural estrogen in the body. Femtrace is sometimes used as part of cancer treatment in women and men.
Femtrace may also be used for other purposes not listed in this medication guide.
Femtrace side effects
Get emergency medical help if you have any of these signs of an allergic reaction to Femtrace: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using Femtrace and call your doctor at once if you have a serious side effect such as:
Less serious Femtrace side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Femtrace
You should not take Femtrace if you are allergic to estradiol, or if you have:
Taking hormones can increase your risk of blood clots, stroke, or heart attack, especially if you have risk factors such as diabetes, high blood pressure, high cholesterol or triglycerides, smoking, or being overweight.
To make sure you can safely take Femtrace, tell your doctor if you have any of these other conditions:
FDA pregnancy category X. Femtrace can harm an unborn baby or cause birth defects. Do not use Femtrace if you are pregnant. Tell your doctor right away if you become pregnant during treatment. Femtrace can pass into breast milk and may harm a nursing baby. This medication may also slow breast milk production. You should not breast-feed while you are taking Femtrace. Estradiol should not be used to prevent heart disease, stroke, or dementia, because Femtrace may actually increase your risk of developing these conditions.
Relate drugs
- Alora
- Alora skin patch
- Climara
- Conjugated estrogens
- Conjugated estrogens (Intravenous)
- Conjugated estrogens (Oral)
- Conjugated estrogens synthetic a
- Conjugated estrogens synthetic b
- Cenestin
- Delestrogen injection
- Depo-Estradiol injection
- Divigel
- Divigel 0.75 mg/packet
- Divigel 1.25 mg/packet
- Dotti skin patch
- Elestrin
- Enjuvia
- Esclim
- Esterified estrogens
- Estrace
- Estraderm
- Estradiol
- Estradiol (Transdermal)
- Estradiol injection
- Estradiol Patch skin patch
- Estradiol topical
- Estradiol transdermal skin patch
- Estradiol vaginal
- Estrasorb
- Estrogel
- EstroGel Pump
- Estropipate
- Evamist
- Femring
- Femtrace
- Imvexxy
- Menostar
- Minivelle
- Minivelle skin patch
- Ogen .625
- Ogen 1.25
- Ogen 2.5
- Ortho-Est
- Premarin
- Premarin (Conjugated estrogens Intravenous)
- Premarin (Conjugated estrogens Oral)
- Vivelle
- Vivelle-Dot
- Vivelle-Dot skin patch
How to use Femtrace
Take Femtrace exactly as it was prescribed for you. Do not use the medication in larger amounts, or use it for longer than recommended by your doctor.
Long-term Femtrace treatment may increase your risk of breast cancer, ovarian cancer, or uterine cancer. Talk with your doctor about your individual risks before using Femtrace long-term.
Taking progestin while using Femtrace may lower your risk of uterine cancer. If your uterus has not been removed, your doctor may prescribe a progestin for you to take while you are using Femtrace.
Have regular physical exams and mammograms, and self-examine your breasts for lumps on a monthly basis while using Femtrace. Your doctor should check your progress every 3 to 6 months to determine whether you should continue this treatment.
If you need medical tests or surgery, or if you will be on bed rest, you may need to stop using this medication for a short time. Any doctor or surgeon who treats you should know that you are taking Femtrace.
Store Femtrace at room temperature away from moisture, heat, and light.
Warnings
Femtrace can harm an unborn baby or cause birth defects. Do not use Femtrace if you are pregnant. You should not take Femtrace if you have abnormal vaginal bleeding, liver disease, breast or uterine cancer, hormone-dependent cancer, a recent history of heart attack or stroke, if you are pregnant, if you have ever had a blood clot (especially in your lung or your lower body), or if you are allergic to any medicines or food dyes. Taking hormones can increase your risk of blood clots, stroke, or heart attack, especially if you have diabetes, high blood pressure, high cholesterol or triglycerides, if you smoke, or if you are overweight.
Long-term Femtrace treatment may increase your risk of breast cancer, ovarian cancer, or uterine cancer. Talk with your doctor about your individual risks before using Femtrace long-term. Your doctor should check your progress every 3 to 6 months to determine whether you should continue this treatment.
Taking progestin while using Femtrace may lower your risk of uterine cancer. If your uterus has not been removed, your doctor may prescribe a progestin for you to take while you are using Femtrace.
Femtrace should not be used to prevent heart disease, stroke, or dementia, because this medication may actually increase your risk of developing these conditions.
Have regular physical exams and mammograms, and self-examine your breasts for lumps on a monthly basis while using Femtrace.
What other drugs will affect Femtrace
Tell your doctor about all other medicines you use, especially:
This list is not complete and other drugs may interact with Femtrace. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions